Notice Information
Notice Title
Use of PET and MRI imaging facilities, plus [11C] radiopharmaceuticals at Invicro LLC
Notice Description
PET and MRI scanning, radioligand production, and biomarker analysis
Lot Information
Lot 1
PET and MRI scanning, radioligand production, and biomarker analysis * Only UK provider of PET tracers [11C]BU90008, [11C]SA4503, and [18F]BCPP-EF, that are currently used for our studies. * Invicro is located within the Hammersmith Hospital Campus, its location accommodates research participants for image and clinical assessments without increased burden and travel for the participants. While also reducing cost and time to conduct the studies. * [11C] tracers (with short half-life of about 20 minutes) and of [18F] radiotracers (with half-life of about 120 minutes) are produced in house and the short half-life of the [11C] tracers means Invicro's two in-house cyclotron's must be used. Their radioligand development platform means implementation of new tracers is not available at other facilities. * Invicro has the equipment and facilities to collect arterial blood samples during the scans and analyze the quantity of the radioactive metabolites on site.
Procurement Information
The research conducted by the Neurodegeneration Imaging Group requires the use of [11C] radiopharmaceutical, as well as an imaging facility that can provide PET-MR scanners with accompanying arterial line capabilities. Due to the very short half-life of the the [11C] tracers, these research studies are limited to facilities that have an in-house cyclotron. Imanova, trading as Invicro, not only has the in-house production of the [11C] tracers, which have a short half-life of approximately 20 minutes and the [18F] radiotracers with a half-life of approximately 120 minutes, they also host two cyclotrons on site. This coupled with the research facility's location in London, where participants who are participating in the study have clinics has resulted in, for technical reasons, only Invicro being able to provide the tracers and in-house service to deliver the research outputs at present.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-0377ba
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/029714-2022
- Current Stage
- Award
- All Stages
- Award
Procurement Classification
- Notice Type
- Award Notice
- Procurement Type
- Standard
- Procurement Category
- Goods
- Procurement Method
- Limited
- Procurement Method Details
- Award procedure without prior publication of a call for competition
- Tender Suitability
- Not specified
- Awardee Scale
- SME
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33692000 - Medical solutions
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- £1,883,380 £1M-£10M
Notice Dates
- Publication Date
- 21 Oct 20223 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- Not specified
- Award Date
- 12 Oct 20223 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Cancelled
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- UNIVERSITY OF EXETER
- Contact Name
- Sam Barker
- Contact Email
- procurement@exeter.ac.uk
- Contact Phone
- +44 11111
Buyer Location
- Locality
- EXETER
- Postcode
- EX4 4QH
- Post Town
- Exeter
- Country
- England
-
- Major Region (ITL 1)
- TLK South West (England)
- Basic Region (ITL 2)
- TLK4 Devon
- Small Region (ITL 3)
- TLK43 Devon CC
- Delivery Location
- TLK4 Devon
-
- Local Authority
- Exeter
- Electoral Ward
- Duryard and St James
- Westminster Constituency
- Exeter
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-0377ba-2022-10-21T10:52:07+01:00",
"date": "2022-10-21T10:52:07+01:00",
"ocid": "ocds-h6vhtk-0377ba",
"initiationType": "tender",
"tender": {
"id": "UOE/2022/064/SB",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "Use of PET and MRI imaging facilities, plus [11C] radiopharmaceuticals at Invicro LLC",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "33692000",
"description": "Medical solutions"
},
"mainProcurementCategory": "goods",
"description": "PET and MRI scanning, radioligand production, and biomarker analysis",
"lots": [
{
"id": "1",
"description": "PET and MRI scanning, radioligand production, and biomarker analysis * Only UK provider of PET tracers [11C]BU90008, [11C]SA4503, and [18F]BCPP-EF, that are currently used for our studies. * Invicro is located within the Hammersmith Hospital Campus, its location accommodates research participants for image and clinical assessments without increased burden and travel for the participants. While also reducing cost and time to conduct the studies. * [11C] tracers (with short half-life of about 20 minutes) and of [18F] radiotracers (with half-life of about 120 minutes) are produced in house and the short half-life of the [11C] tracers means Invicro's two in-house cyclotron's must be used. Their radioligand development platform means implementation of new tracers is not available at other facilities. * Invicro has the equipment and facilities to collect arterial blood samples during the scans and analyze the quantity of the radioactive metabolites on site.",
"awardCriteria": {
"criteria": [
{
"type": "price"
}
]
},
"hasOptions": false,
"status": "cancelled"
}
],
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33692000",
"description": "Medical solutions"
}
],
"deliveryAddresses": [
{
"region": "UKK4"
}
],
"relatedLot": "1"
}
],
"procurementMethod": "limited",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"coveredBy": [
"GPA"
],
"procurementMethodRationaleClassifications": [
{
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
"id": "D_OUTSIDE_SCOPE",
"description": "The procurement falls outside the scope of application of the directive"
}
],
"procurementMethodRationale": "The research conducted by the Neurodegeneration Imaging Group requires the use of [11C] radiopharmaceutical, as well as an imaging facility that can provide PET-MR scanners with accompanying arterial line capabilities. Due to the very short half-life of the the [11C] tracers, these research studies are limited to facilities that have an in-house cyclotron. Imanova, trading as Invicro, not only has the in-house production of the [11C] tracers, which have a short half-life of approximately 20 minutes and the [18F] radiotracers with a half-life of approximately 120 minutes, they also host two cyclotrons on site. This coupled with the research facility's location in London, where participants who are participating in the study have clinics has resulted in, for technical reasons, only Invicro being able to provide the tracers and in-house service to deliver the research outputs at present."
},
"awards": [
{
"id": "029714-2022-1",
"relatedLots": [
"1"
],
"title": "TBC",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-66510",
"name": "Imanova"
}
]
}
],
"parties": [
{
"id": "GB-FTS-1655",
"name": "University of Exeter",
"identifier": {
"legalName": "University of Exeter",
"id": "RC000653"
},
"address": {
"streetAddress": "Northcote House",
"locality": "Exeter",
"region": "UKK4",
"postalCode": "EX4 4QH",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "Sam Barker",
"telephone": "+44 11111",
"email": "procurement@exeter.ac.uk"
},
"roles": [
"buyer"
],
"details": {
"url": "http://www.exeter.ac.uk",
"buyerProfile": "https://uk.eu-supply.com/ctm/Company/CompanyInformation/Index/53042",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "09",
"description": "Education"
}
]
}
},
{
"id": "GB-FTS-66510",
"name": "Imanova",
"identifier": {
"legalName": "Imanova"
},
"address": {
"locality": "Invicro LLC",
"region": "UKI",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "sme"
}
},
{
"id": "GB-FTS-1656",
"name": "Royal Court of Justice",
"identifier": {
"legalName": "Royal Court of Justice"
},
"address": {
"locality": "London",
"countryName": "United Kingdom"
},
"roles": [
"reviewBody"
]
}
],
"buyer": {
"id": "GB-FTS-1655",
"name": "University of Exeter"
},
"contracts": [
{
"id": "029714-2022-1",
"awardID": "029714-2022-1",
"title": "TBC",
"status": "active",
"value": {
"amount": 1883380,
"currency": "GBP"
},
"dateSigned": "2022-10-13T00:00:00+01:00"
}
],
"bids": {
"statistics": [
{
"id": "1",
"measure": "bids",
"relatedLot": "1",
"value": 1
}
]
},
"language": "en"
}